Our verdict
Noom Med pairs prescribing with its coaching and behavior-change tools. For Zepbound, the GLP-1 cost estimator shows published drug-program prices you can add to Noom’s separate care fee. Compounded microdose plans use a different subscription structure, so confirm the selected program’s full term charge and renewal rather than treating a starting offer as a continuing monthly bill.
Main trade-offs
- Microdose starting offer is not a molecule-specific selected quote
- Initial subscription and medication periods differ
Disclosure: Aminoscope is reader-supported. We may earn a commission from partner links, at no extra cost to you. This never changes our assessment. How we make money.
Compounded medicines are not FDA-approved. A licensed clinician must assess whether treatment is appropriate; availability does not establish safety or benefit.
Good fit
Adults who want Noom’s coaching alongside clinical care and can compare the full selected program cost.
Consider other options if
Anyone wanting a public guaranteed per-molecule compounded price, a single-month commitment on the microdose offer, or a routine refund for an unused part of a billing period.
Cost and care at a glance
- Category
- GLP-1 telehealth
- Published cost
- Zepbound care $39 initially, then $129/mo plus medication; microdose offer from $79 plus tax, then $179/mo plus tax on a 12-week subscription; final program price varies.
- Medications
- Compounded semaglutide · Compounded tirzepatide · Branded
- Insurance
- Works with insurance
- Visit
- Quiz intake / Async intake
- Availability
- Not all 50 states
Our review in detail
Full assessment
Noom Med pairs prescribing with Noom’s coaching and behavior-change tools. The billing depends on the route: its Zepbound page advertises $39 to start and $129 monthly for care, with medication extra. The microdose landing includes compounded medication and advertises a generic starting offer followed by a 12-week subscription. That is not a separate confirmed price for each molecule. Check the selected program, full term charge and renewal before paying; partial billing periods generally are not refunded.
What it is
Noom Med is Noom’s clinical weight-management service alongside its coaching app. Its current catalog lists brand-name and compounded options, including Wegovy, Zepbound, Ozempic, Mounjaro, Wegovy pill, Foundayo, metformin and generic liraglutide. The microdose landing names compounded semaglutide and tirzepatide offerings. A clinical evaluation determines eligibility; a catalog listing is not a promise that a particular prescription or delivery route will be available to you.
How care works
Licensed clinicians prescribe and manage medication when clinically appropriate, with coaching, habit tools and ongoing support through Noom. The public Zepbound pathway mentions labs, but a routine selected lab charge is not established here. The Eden review covers a service that offers compounded semaglutide alongside branded Ozempic, Wegovy and Zepbound. Medication coverage and home delivery depend on the plan and insurance or cash-pay route. The public pages do not establish an individual dispensing pharmacy or a complete product-specific state list.
Costs, billing and cancellation
For the brand-name route, Noom’s Zepbound page advertises $39 to start and $129 a month for ongoing care. For a published price to compare against, the CoreAge Rx review shows semaglutide starting at $79 a month and tirzepatide at $129. Medication is extra; self-pay LillyDirect Zepbound vials are advertised from $299 a month. That drug floor is not an all-in Noom charge or a guaranteed price at every dose.
The current microdose landing names both compounded semaglutide and tirzepatide offerings, with plans from $79 plus tax for an initial three-week subscription and four weeks of medication, then $179 per month plus tax for a 12-week subscription. This pricing is for new accounts effective July 27, 2026, and the page says the final price depends on program selection. It does not establish a separate $79/$179 quote for each molecule, an exact charge date or the full 12-week charge. Confirm the amount payable before subscribing.
A still-live Noom blog gives $79 followed by $199, while older March 31 footnotes give $149 followed by $299. The newer dated landing is the better reference for the advertised starting offer, but confirm the selected price because the blog still differs.
Subscriptions renew automatically. Cancel through the account before 11:59 p.m. Eastern on the day before the next billing date; third-party subscriptions follow that store’s cancellation process. Partially used periods generally are not refunded except at Noom’s discretion. California residents have a three-business-day rescission right under the terms. Confirm tax, selected term, coverage and medication charges before enrolling.
Medication and evidence
Noom’s current catalog lists brand-name and compounded options; its microdose landing names compounded semaglutide and tirzepatide. Compounded medications are not FDA-approved, and results from trials of branded drugs do not establish equivalent results for a compounded formulation or a microdose program. A clinician must determine which medication and formulation are appropriate; the catalog alone does not establish eligibility.
Pros and watch-outs
What we like
- Behavior-change tools and clinical support in one service
- Brand-name care fee is distinguished from medication cost
- Current microdose landing states initial subscription, medication period and later commitment
- Public subscription and cancellation terms available
Watch-outs
- Microdose starting offer is not a molecule-specific selected quote
- Initial subscription and medication periods differ
- A live blog carries conflicting, older prices
- The later 12-week subscription is not a cancel-after-one-month price
- Individual pharmacy, state eligibility and lab charges need confirmation
Best for
Adults who want Noom’s coaching alongside clinical care and can compare the full selected program cost.
Who should look elsewhere
Anyone wanting a public guaranteed per-molecule compounded price, a single-month commitment on the microdose offer, or a routine refund for an unused part of a billing period.
Research relevant to Noom Med
Explore the evidence and its limits. Findings apply to the formulation, route and population studied; they do not establish the quality or effectiveness of a provider’s products.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4 and SELECT, plus oral and higher-dose semaglutide trials: weight loss, withdrawal, cardiovascular benefit and the limits of comparison.
- Zepbound vs Wegovy: what the trials actually show
SURMOUNT-5 favored Zepbound over Wegovy 1.7 or 2.4 mg injection. Compare the weight results, safety and labeled uses—and why tablets and 7.2 mg need separate evidence.
- “Microdosing” GLP-1 drugs: a trend, not a protocol. What the evidence says
What GLP-1 microdosing means, how it differs from approved maintenance doses, and why daily dose-ranging studies cannot validate a weekly microdose.
- Orforglipron: the oral non-peptide GLP-1, and what the trials actually show
A once-daily small-molecule GLP-1 pill with no food restrictions — from Phase 2 proof of concept to the Phase 3 read-outs. The evidence, graded.
How Noom Med compares
A few alternatives worth a look, depending on what you’re optimizing for.
Our Found review and Shed review describe what each service publishes about pricing, billing and cancellation.
FoundMultiple medication pathways and insurance for clinical visits
See Found →Shed
A wide range of GLP-1 formats (injection, drops, lozenges, microdose)
See Shed →
RoBranded treatment with medication insurance navigation
See Ro →
More GLP-1 telehealth reviews: Corsica HealthDocberryVirgo-MedsMEDGmMetaboost RxLyfe RX
Research & data
How we assessed this. This review is based on Noom Med’s own website and published terms, read for pricing transparency, clinical oversight, medication clarity and access against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Does Noom’s $129 fee include Zepbound?
- No. The Zepbound page lists $39 to start and $129 monthly for care; medication is extra. Its LillyDirect vial offer starts at $299 monthly, with the selected dose and eligibility affecting the actual drug cost.
- Is microdose semaglutide or tirzepatide $79?
- The current landing names both offerings but gives a generic starting price. It advertises from $79 plus tax for an initial three-week subscription and four weeks of medication, then $179 per month plus tax for a 12-week subscription. Final pricing depends on program selection, so this is not a separate confirmed quote for each drug.
- Why do other Noom pages show different prices?
- A live blog still says $79 then $199 and contains earlier March 31 footnotes with $149/$299. The newer landing dates its new-account pricing to July 27. Confirm the selected program rather than treating the older figures as a current dual-action offer.
- How do I stop the next renewal?
- The terms require cancellation before 11:59 p.m. Eastern on the day before billing. Partial periods generally are not refunded. California residents have a three-business-day rescission right; third-party subscriptions use the relevant store’s cancellation process.
- Is Noom Med legit?
- Noom Med is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide, Compounded tirzepatide and branded medication. Its stated availability: Not all 50 states. What it publishes up front: Zepbound care $39 initially, then $129/mo plus medication; microdose offer from $79 plus tax, then $179/mo plus tax on a 12-week subscription; final program price varies. It states it works with insurance. Before you pay, ask in writing about your selected charge, billing interval, supply and required fees.